Hi, what are you looking for?
[FULL LETTER] After Mylan Responded aggressively to Teva's bid, Erez Vigodman says in an open letter to Robert Coury: Shareholders won't benefit from Mud...
Board concludes that approach grossly undervalues Mylan, includes Teva stock, and would expose Mylan to a problematic culture and leadership with poor record of...
The body’s immune system can easily recognize its own cells
Shares of Teva Pharmaceutical Industries traded up 0.87% on Monday, hitting $62.52.
It's tictoc, tictoc, for Teva.
Berenberg analysts see insurance companies pressuring MS patients to switch to generic versions of Copaxone. Last year, Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE:...
Bloomberg reports that increased competition with cheaper generics may push Teva to make a major acquisition soon. Perrigo Company (NYSE:PRGO; TASE:PRGO) may be a...
Here is our list of the ten companies that made the biggest or at least the most headlines this past year, for good...
– Relations between Teva and Biotec have deteriorated into a legal dispute and an entanglement with the Russian authorities. – After years of...
Israeli biomed firm Mapi Pharma Ltd., which is a development stage pharmaceutical company, announced that the first patient was treated in the company’s Phase...